Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
This piece breaks down the core influences on market indices, from macro indicators to liquidity, helping you anticipate possible moves.
27,686 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
In Q1, Berkshire Hathaway slashed 16 holdings, leaving 26 positions and pushing four top stocks to dominate more than...
Micron just broke mold by turning AI-driven memory demand into a clear investment thesis. This guide explains why the...
A wave of bitcoin etfs outflows billion sent ripples through the market. This guide breaks down what happened, why it...
A disciplined investment approach blends steady dividend payers with selective high-yield assets to produce durable i...
Investing in altcoins means looking beyond hype. This guide compares Stellar and XRP through the lens of real-world a...
Lucid faces a pivotal year as production scales and capital needs rise. This guide outlines plausible paths for where...
As NVIDIA readies its GTC keynote, memory names MU and SNDK swing on speculation about a new inference chip that coul...
Banks and financial-services shares are under pressure as rising yields meet renewed fears about private-credit lende...
NVIDIA shares jumped roughly 2% on Monday after announcing energy-grid partnerships and BioNeMo collaborations, signa...
Markets grapple with a hypothetical energy shock after a White House remark suggesting oil could surge to $200 per ba...
Trump’s renewed push to revive the Rush Hour franchise is drawing investor attention. Analysts say licensing, streami...